kabutan

TORAY INDUSTRIES,INC.(3402) Summary

3402
TSE Prime
TORAY INDUSTRIES,INC.
1,117.5
JPY
-23.0
(-2.02%)
Apr 30, 2:45 pm JST
6.96
USD
Apr 30, 1:45 am EDT
Result
PTS
outside of trading hours
1,117.7
Apr 30, 2:45 pm JST
Summary Chart Historical News Financial Result
PER
19.8
PBR
0.92
Yield
1.79%
Margin Trading Ratio
1.17
Stock Price
Apr 30, 2026
Opening Apr 30, 9:00 am
1,122.0 JPY 7.00 USD
Previous Close Apr 28
1,140.5 JPY 7.16 USD
High Apr 30, 9:00 am
1,125.0 JPY 7.02 USD
Low Apr 30, 9:19 am
1,101.5 JPY 6.87 USD
Volume
2,456,500
Trading Value
2.74B JPY 0.02B USD
VWAP
1114.81 JPY 6.94 USD
Minimum Trading Value
111,750 JPY 696 USD
Market Cap
1.68T JPY 0.01T USD
Number of Trades
4,445
Liquidity & Number of Trades
As of Apr 30, 2026
Liquidity
High
1-Year Average
7,323
1-Year High Aug 8, 2025
42,244
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 228,600 1,874,500 8.20
Apr 17, 2026 230,400 1,898,400 8.24
Apr 10, 2026 246,700 1,736,300 7.04
Apr 3, 2026 296,500 1,810,200 6.11
Mar 27, 2026 334,600 1,746,400 5.22
Company Profile
TORAY INDUSTRIES, INC. is the largest synthetic fiber manufacturer and a world leader in carbon fiber production. The company also operates in pharmaceuticals, electronic materials, and water treatment reverse osmosis membranes.
Sector
Texstiles & Apparels
TORAY INDUSTRIES, INC. is a comprehensive chemical manufacturer with business operations spanning various sectors including fibers and textiles, performance chemicals, carbon fiber composite materials, environment and engineering, and life sciences. In its fiber business, the company produces yarns, woven and knitted fabrics, non-woven fabrics, artificial leather, and apparel products made from materials such as nylon and polyester. The performance chemicals division manufactures resins, resin-molded products, films, and electronic and information materials. TORAY INDUSTRIES, INC. also engages in carbon fiber composite materials business, environment and engineering operations including functional membranes for water treatment, and life science ventures producing pharmaceuticals and medical devices. With numerous subsidiaries and affiliated companies worldwide, the company conducts business across a wide range of fields on a global scale.